The appetite control and suppressants market size has grown strongly in recent years. It will grow from $3.84 billion in 2025 to $4.11 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to obesity prevalence, dietary supplement demand, lifestyle changes, fitness awareness, otc product availability.
The appetite control and suppressants market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to weight management awareness, natural supplement preference, digital wellness platforms, preventive healthcare focus, aging population. Major trends in the forecast period include rising demand for weight management solutions, growth of natural and herbal suppressants, expansion of otc appetite control products, increased focus on lifestyle-based weight loss, growth of online and direct-to-consumer sales.
The rising prevalence of overweight and obesity is expected to drive the growth of the appetite control and suppressants market in the coming years. Overweight and obesity are conditions characterized by excessive body fat accumulation that can negatively impact health. The increase in these conditions is primarily due to high-calorie diets rich in sugars and unhealthy fats, combined with insufficient nutrient intake and sedentary lifestyles. Appetite control and suppressants help manage overweight and obesity by reducing hunger signals, limiting calorie intake, and supporting effective weight management. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that in 2023, 23 states had adult obesity prevalence of 35% or higher, and all 50 states recorded obesity rates of at least 20%. Therefore, the rising rates of overweight and obesity are fueling growth in the appetite control and suppressants market.
Key companies in the appetite control and suppressants market are focusing on innovative products, such as natural appetite suppressant drinks, to provide safer and more effective weight management solutions. Natural appetite suppressant drinks are beverages formulated from herbs, fruits, or fibers that naturally reduce hunger and control cravings. For instance, in December 2024, Nestlé S.A., a Switzerland-based food and beverage company, launched Boost Pre-Meal Hunger Support, a natural appetite suppressant drink. Designed to mimic the effects of GLP-1-based medications like Ozempic and Wegovy, this 45-calorie, 10-gram whey protein shot is intended to be consumed 10-30 minutes before meals. It stimulates the body’s natural GLP-1 hormone response to reduce appetite and increase satiety, using fast-digesting peptides and whey protein microgels to extend fullness, making it ideal for individuals following weight-loss plans or GLP-1-based treatments.
In January 2024, Roche Holding AG, a Switzerland-based multinational healthcare company, acquired Carmot Therapeutics for USD 2.7 billion. Through this acquisition, Roche aims to expand its portfolio in obesity and metabolic disease therapeutics by integrating Carmot’s clinical and preclinical assets, including dual GLP-1/GIP receptor agonists, and leveraging its Chemotype Evolution discovery platform to accelerate the development of innovative appetite control and weight-management therapies. Carmot Therapeutics Inc., based in the US, is a biotech company specializing in novel therapeutics for obesity, diabetes, and other metabolic disorders.
Major companies operating in the appetite control and suppressants market are Nestlé S.A, GlaxoSmithKline plc, Sanofi S.A, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Herbalife Nutrition Ltd, Amway Corporation, GNC Holdings Inc., Medifast Inc., Nature's Sunshine Products Inc., The Boots Company PLC, BPI Sports LLC, Grenade (UK) Limited, Currax Pharmaceuticals LLC, VIVUS Inc, Orexigen Therapeutics Inc, NOW Health Group Inc, Nutrabay Retail Private Limited, GAT Sport.
North America was the largest region in the appetite control and suppressants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the appetite control and suppressants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the appetite control and suppressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the appetite control and suppressants market by raising costs for herbal extracts, pharmaceutical ingredients, and nutritional inputs used in prescription, OTC, and natural appetite suppressants. Meal replacements, fiber supplements, and herbal product segments are most impacted, especially in North America and Asia-Pacific where imports dominate sourcing. Positively, tariffs are driving local sourcing of botanicals and in-country supplement manufacturing, strengthening regional supply chains.
The appetite control and suppressants market research report is one of a series of new reports that provides appetite control and suppressants market statistics, including appetite control and suppressants industry global market size, regional shares, competitors with a appetite control and suppressants market share, detailed appetite control and suppressants market segments, market trends and opportunities, and any further data you may need to thrive in the appetite control and suppressants industry. This appetite control and suppressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Appetite control and suppressants refer to methods, substances, or strategies used to manage hunger and reduce the urge to eat, supporting weight management. These approaches include natural methods such as consuming high-fiber or high-protein foods, staying hydrated, and maintaining regular sleep and stress patterns, as well as medical or pharmaceutical interventions that suppress appetite.
The main product types of appetite control and suppressants include prescription appetite suppressants, over-the-counter (OTC) appetite suppressants, natural or herbal suppressants, meal replacements and shakes, and dietary fiber supplements. Prescription appetite suppressants are medications prescribed by healthcare professionals to help curb hunger or cravings and support weight loss. These products are available in forms such as tablets, capsules, powders, gummies, chews, liquids, and bars. They are distributed through pharmacies, drugstores, supermarkets, hypermarkets, online retailers, specialty stores, and healthcare providers or clinics, serving a wide range of end-users, including adults, adolescents, and the elderly.
The appetite control and suppressants market consist of sales of thermogenic appetite suppressants, serotonin-based appetite suppressants, fat binders, stimulant-free appetite suppressants, lipase inhibitors, glucomannan-based supplements, and garcinia cambogia-based products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The appetite control and suppressants market size is expected to see strong growth in the next few years. It will grow to $5.35 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to weight management awareness, natural supplement preference, digital wellness platforms, preventive healthcare focus, aging population. Major trends in the forecast period include rising demand for weight management solutions, growth of natural and herbal suppressants, expansion of otc appetite control products, increased focus on lifestyle-based weight loss, growth of online and direct-to-consumer sales.
The rising prevalence of overweight and obesity is expected to drive the growth of the appetite control and suppressants market in the coming years. Overweight and obesity are conditions characterized by excessive body fat accumulation that can negatively impact health. The increase in these conditions is primarily due to high-calorie diets rich in sugars and unhealthy fats, combined with insufficient nutrient intake and sedentary lifestyles. Appetite control and suppressants help manage overweight and obesity by reducing hunger signals, limiting calorie intake, and supporting effective weight management. For example, in September 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that in 2023, 23 states had adult obesity prevalence of 35% or higher, and all 50 states recorded obesity rates of at least 20%. Therefore, the rising rates of overweight and obesity are fueling growth in the appetite control and suppressants market.
Key companies in the appetite control and suppressants market are focusing on innovative products, such as natural appetite suppressant drinks, to provide safer and more effective weight management solutions. Natural appetite suppressant drinks are beverages formulated from herbs, fruits, or fibers that naturally reduce hunger and control cravings. For instance, in December 2024, Nestlé S.A., a Switzerland-based food and beverage company, launched Boost Pre-Meal Hunger Support, a natural appetite suppressant drink. Designed to mimic the effects of GLP-1-based medications like Ozempic and Wegovy, this 45-calorie, 10-gram whey protein shot is intended to be consumed 10-30 minutes before meals. It stimulates the body’s natural GLP-1 hormone response to reduce appetite and increase satiety, using fast-digesting peptides and whey protein microgels to extend fullness, making it ideal for individuals following weight-loss plans or GLP-1-based treatments.
In January 2024, Roche Holding AG, a Switzerland-based multinational healthcare company, acquired Carmot Therapeutics for USD 2.7 billion. Through this acquisition, Roche aims to expand its portfolio in obesity and metabolic disease therapeutics by integrating Carmot’s clinical and preclinical assets, including dual GLP-1/GIP receptor agonists, and leveraging its Chemotype Evolution discovery platform to accelerate the development of innovative appetite control and weight-management therapies. Carmot Therapeutics Inc., based in the US, is a biotech company specializing in novel therapeutics for obesity, diabetes, and other metabolic disorders.
Major companies operating in the appetite control and suppressants market are Nestlé S.A, GlaxoSmithKline plc, Sanofi S.A, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Herbalife Nutrition Ltd, Amway Corporation, GNC Holdings Inc., Medifast Inc., Nature's Sunshine Products Inc., The Boots Company PLC, BPI Sports LLC, Grenade (UK) Limited, Currax Pharmaceuticals LLC, VIVUS Inc, Orexigen Therapeutics Inc, NOW Health Group Inc, Nutrabay Retail Private Limited, GAT Sport.
North America was the largest region in the appetite control and suppressants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the appetite control and suppressants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the appetite control and suppressants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the appetite control and suppressants market by raising costs for herbal extracts, pharmaceutical ingredients, and nutritional inputs used in prescription, OTC, and natural appetite suppressants. Meal replacements, fiber supplements, and herbal product segments are most impacted, especially in North America and Asia-Pacific where imports dominate sourcing. Positively, tariffs are driving local sourcing of botanicals and in-country supplement manufacturing, strengthening regional supply chains.
The appetite control and suppressants market research report is one of a series of new reports that provides appetite control and suppressants market statistics, including appetite control and suppressants industry global market size, regional shares, competitors with a appetite control and suppressants market share, detailed appetite control and suppressants market segments, market trends and opportunities, and any further data you may need to thrive in the appetite control and suppressants industry. This appetite control and suppressants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Appetite control and suppressants refer to methods, substances, or strategies used to manage hunger and reduce the urge to eat, supporting weight management. These approaches include natural methods such as consuming high-fiber or high-protein foods, staying hydrated, and maintaining regular sleep and stress patterns, as well as medical or pharmaceutical interventions that suppress appetite.
The main product types of appetite control and suppressants include prescription appetite suppressants, over-the-counter (OTC) appetite suppressants, natural or herbal suppressants, meal replacements and shakes, and dietary fiber supplements. Prescription appetite suppressants are medications prescribed by healthcare professionals to help curb hunger or cravings and support weight loss. These products are available in forms such as tablets, capsules, powders, gummies, chews, liquids, and bars. They are distributed through pharmacies, drugstores, supermarkets, hypermarkets, online retailers, specialty stores, and healthcare providers or clinics, serving a wide range of end-users, including adults, adolescents, and the elderly.
The appetite control and suppressants market consist of sales of thermogenic appetite suppressants, serotonin-based appetite suppressants, fat binders, stimulant-free appetite suppressants, lipase inhibitors, glucomannan-based supplements, and garcinia cambogia-based products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Appetite Control and Suppressants Market Characteristics
3. Appetite Control and Suppressants Market Supply Chain Analysis
4. Global Appetite Control and Suppressants Market Trends and Strategies
5. Appetite Control and Suppressants Market Analysis of End Use Industries
7. Global Appetite Control and Suppressants Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Appetite Control and Suppressants Total Addressable Market (TAM) Analysis for the Market
9. Appetite Control and Suppressants Market Segmentation
10. Appetite Control and Suppressants Market Regional and Country Analysis
11. Asia-Pacific Appetite Control and Suppressants Market
12. China Appetite Control and Suppressants Market
13. India Appetite Control and Suppressants Market
14. Japan Appetite Control and Suppressants Market
15. Australia Appetite Control and Suppressants Market
16. Indonesia Appetite Control and Suppressants Market
17. South Korea Appetite Control and Suppressants Market
18. Taiwan Appetite Control and Suppressants Market
19. South East Asia Appetite Control and Suppressants Market
20. Western Europe Appetite Control and Suppressants Market
21. UK Appetite Control and Suppressants Market
22. Germany Appetite Control and Suppressants Market
23. France Appetite Control and Suppressants Market
24. Italy Appetite Control and Suppressants Market
25. Spain Appetite Control and Suppressants Market
26. Eastern Europe Appetite Control and Suppressants Market
27. Russia Appetite Control and Suppressants Market
28. North America Appetite Control and Suppressants Market
29. USA Appetite Control and Suppressants Market
30. Canada Appetite Control and Suppressants Market
31. South America Appetite Control and Suppressants Market
32. Brazil Appetite Control and Suppressants Market
33. Middle East Appetite Control and Suppressants Market
34. Africa Appetite Control and Suppressants Market
36. Appetite Control and Suppressants Market Competitive Landscape and Company Profiles
37. Appetite Control and Suppressants Market Other Major and Innovative Companies
40. Appetite Control and Suppressants Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Appetite Control And Suppressants Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses appetite control and suppressants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for appetite control and suppressants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The appetite control and suppressants market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Prescription Appetite Suppressants; Over-The-Counter (OTC) Appetite Suppressants; Natural Or Herbal Appetite Suppressants; Meal Replacements And Shakes; Dietary Fiber Supplements2) By Form: Tablets And Capsules; Powders; Gummies And Chews; Liquids; Bars
3) By Distribution Channel: Pharmacies And Drug Stores; Supermarkets And Hypermarkets; Online Retailers; Specialty Stores; Healthcare Providers And Clinics
4) By End-User: Adults; Geriatric; Adolescents
Subsegments:
1) By Prescription Appetite Suppressants: Phentermine; Lorcaserin (Belviq); Diethylpropion; Other Prescription Drugs2) By Over-The-Counter (OTC) Suppressants: Herbal Supplements; Fiber-Based Suppressants; Caffeine-Based Products; Meal Replacements
3) By Natural or Herbal Appetite Suppressants: Green Tea Extract; Garcinia Cambogia; Glucomannan; Yerba Mate; Fenugreek; Conjugated Linoleic Acid
4) By Meal Replacements And Shakes: Protein Shakes; Meal Replacement Bars; Low-Calorie Shakes; High-Protein Smoothies; Keto Meal Replacements
5) By Dietary Fiber Supplements: Glucomannan; Psyllium Husk; Methylcellulose; Inulin; Beta-Glucan
Companies Mentioned: Nestlé S.A; GlaxoSmithKline plc; Sanofi S.A; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Novo Nordisk A/S; Herbalife Nutrition Ltd; Amway Corporation; GNC Holdings Inc.; Medifast Inc.; Nature's Sunshine Products Inc.; The Boots Company PLC; BPI Sports LLC; Grenade (UK) Limited; Currax Pharmaceuticals LLC; VIVUS Inc; Orexigen Therapeutics Inc; NOW Health Group Inc; Nutrabay Retail Private Limited; GAT Sport
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Appetite Control and Suppressants market report include:- Nestlé S.A
- GlaxoSmithKline plc
- Sanofi S.A
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Novo Nordisk A/S
- Herbalife Nutrition Ltd
- Amway Corporation
- GNC Holdings Inc.
- Medifast Inc.
- Nature's Sunshine Products Inc.
- The Boots Company PLC
- BPI Sports LLC
- Grenade (UK) Limited
- Currax Pharmaceuticals LLC
- VIVUS Inc
- Orexigen Therapeutics Inc
- NOW Health Group Inc
- Nutrabay Retail Private Limited
- GAT Sport
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.11 Billion |
| Forecasted Market Value ( USD | $ 5.35 Billion |
| Compound Annual Growth Rate | 6.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
